At the news
? BEARISHIMPACT 7/10 CLUSTER filed Apr 8, 2026 at 20:00 ET
Two top executives at Mineralys Therapeutics, the CEO and Chief Medical Officer, sold shares in a concentrated 7-day window, generating over $1.1 million in proceeds. The sales are open-market transactions, indicating deliberate divestment rather than routine equity management.
- CEO Jon Congleton sold $422,000 worth of shares in a single open-market transaction on April 13, 2026.
- Chief Medical Officer Rodman David Malcom sold $548,672 in shares across two days (April 13 and 15), following derivative exercises totaling $6,857.
- Total open-market sale value from the cluster: $1.1M over 7 days, representing 0.048% of the company's $2.3B market cap.
- All transactions were coded as S (open-market sale) or M (exercise of derivative), with non-cash derivative exercises also occurring.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access